Professional Documents
Culture Documents
Letters to the Editor
summarized the evidence behind the popular herb.1 His review commented that there are no
reported drug interactions with the use of echinacea. Although there are no reports of any
significant drug interactions with echinacea, it has been suggested that use of echinacea for
more than eight weeks could cause hepatotoxicity; therefore, echinacea should not be used
with other known hepatotoxic drugs such as amiodarone, methotrexate, and ketoconazole.2
Even the concurrent use of acetaminophen and echinacea may cause an increase in the
incidence of hepatotoxicity.3 This is particularly important because echinacea and
acetaminophen are frequently used to treat the symptoms of the common cold.
In my opinion, the use of echinacea should be restricted to a maximum of two weeks for acute
illness. I believe that the chronic use of echinacea should be discouraged because its use in
the prevention of colds has not been proved beneficial, can lead to increased risk of
hepatotoxicity, and may have the potential for immunosuppression. Even though echinacea
does not have any documented drug interactions, we must be vigilant in monitoring for
potential interactions and adverse effects.
1. Kligler B.
Echinacea. Am Fam Physician.
2003;67:77–80....
https://www.aafp.org/afp/2003/0815/p617.html 1/3
8/6/2021 Chronic Use of Echinacea Should Be Discouraged - Letters to the Editor - American Family Physician
in reply: I agree with Dr. Chua that the long-term use of echinacea should be discouraged
based on the fact that there is no evidence that such use is effective in the prevention of upper
respiratory illness. However, regarding the issue of hepatotoxicity and echinacea, evidence is
lacking. The initial concerns regarding hepatotoxicity with long-term use of echinacea arose
from the presence of alkaloids in the pyrrolizidine family in certain parts of the echinacea
plant. Pyrrolizidine alkaloids with an unsaturated nucleus, such as those found in comfrey, are
known to be hepatotoxic with long-term use. However, the pyrrolizidine alkaloids found in
echinacea, isotussilagine and tussilagine, possess a saturated nucleus.1 Currently, this
category of pyrrolizidines has not been found to be hepatotoxic. Thus, I feel that Dr. Chua's
advice to discourage the concurrent use of acetaminophen and echinacea is not based on
current evidence and may lead to unwarranted concerns for physicians and patients regarding
the use of this herb. It also is notable that there have been no published reports of significant
hepatotoxicity with echinacea, despite its widespread use.
REFERENCES
1. Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health-care
professionals. London: Pharmaceutical Press, 1996.
Letters submitted for publication in AFP must not be submitted to any other publication.
Possible conflicts of interest must be disclosed at time of submission. Submission of a letter
will be construed as granting the AAFP permission to publish the letter in any of its
publications in any form. The editors may edit letters to meet style and space requirements.
This series is coordinated by Kenny Lin, MD, MPH, Associate Deputy Editor for AFP Online.
0 comments
lock Log In () to comment
https://www.aafp.org/afp/2003/0815/p617.html 2/3
8/6/2021 Chronic Use of Echinacea Should Be Discouraged - Letters to the Editor - American Family Physician
Copyright © 2003 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may
make one printout of the material and
may use that printout only for his or her personal, non-commercial reference. This material may not
otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now
known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org
(mailto:afpserv@aafp.org) for copyright questions and/or permission requests.
https://www.aafp.org/afp/2003/0815/p617.html 3/3